Our laboratory has recently demonstrated that PKD2-mediated signaling pathways, including RAS/RAF/ERK, PI3K/AKT/mTOR, and NF-κB, are activated in human CRC [18]. The gene discussed is RAF1; the disease is colorectal carcinoma.